|
|
Post by notamnkdmillionaire on Aug 12, 2014 13:36:06 GMT -5
Would to release for 8 weeks straight, one Technosphere licensing deals. One a week. That might help us get back up to $8.
|
|
|
|
Post by vissertrades on Aug 12, 2014 13:43:34 GMT -5
Or push us below $2!!!!!!!!!!!!!!!!!!!!!! Seriously, this sucks!
|
|
|
|
Post by mdcenter61 on Aug 12, 2014 13:52:32 GMT -5
Would to release for 8 weeks straight, one Technosphere licensing deals. One a week. That might help us get back up to $8.
I seriously can't afford any more good news - LOL!
I am pretty much feeling what your avatar baby is.
|
|
|
|
Post by kc on Aug 12, 2014 17:22:21 GMT -5
But the deals need to go thru FDA approval as to their effectiveness so it takes time.
|
|
|
|
Post by notamnkdmillionaire on Aug 12, 2014 18:21:31 GMT -5
But the deals need to go thru FDA approval as to their effectiveness so it takes time. Deals don't need FDA approval. Clinical trials do. I am only talking about license deals to adapt a drug using technosphere. |
|
|
|
Post by jpg on Aug 12, 2014 18:35:15 GMT -5
But the deals need to go thru FDA approval as to their effectiveness so it takes time. The problem is that good news seems to drop Mannkind stock price... So by that 'logic' every good piece of info will make us worst off. Let us collectively hope for no more good news! Short term the market is a big scam. Long term (which I struggle to define) we will do well. We have been overall right so far. I personally was very happy with both CC yesterday and as a clinician I am impressed with what Sanofi said and how they said it. 1- We have FDA approval with a clean label. 2- As a partner we have one of the 3 best BP in the world. The only better partner I could have wished for would have been Novartis if they decided to make a big push into the diabetic/ insulin space and use Afrezza as their 'star product'. 3- Mannkind is now financially safe from more dilution. Not certain what more we long term investors could want really. I have been a biotech investor long enough to know ups and downs are not 'sticky'. I suspect that what really scared shorts before the partnership announcement was the possibility of there being a buyout. They would have been powerless and very vulnerable. Now we are certain there will be no buyout the shorts should feel much more secure and in control till buyers smell an opportunity. It will happen. When? I don't know obviously but it will happen. The opportunity is just too obvious and getting bigger every time we drop in market cap. The last time I bought was about 2 years ago and I was paying 2-3$ a share. From my perspective now seems to be an amazingly better risk adjusted entry point. JPG |
|
|
|
Post by joeypotsandpans on Aug 12, 2014 19:10:26 GMT -5
But the deals need to go thru FDA approval as to their effectiveness so it takes time. The problem is that good news seems to drop Mannkind stock price... So by that 'logic' every good piece of info will make us worst off. Let us collectively hope for no more good news! Short term the market is a big scam. Long term (which I struggle to define) we will do well. We have been overall right so far. I personally was very happy with both CC yesterday and as a clinician I am impressed with what Sanofi said and how they said it. 1- We have FDA approval with a clean label. 2- As a partner we have one of the 3 best BP in the world. The only better partner I could have wished for would have been Novartis if they decided to make a big push into the diabetic/ insulin space and use Afrezza as their 'star product'. 3- Mannkind is now financially safe from more dilution. Not certain what more we long term investors could want really. I have been a biotech investor long enough to know ups and downs are not 'sticky'. I suspect that what really scared shorts before the partnership announcement was the possibility of there being a buyout. They would have been powerless and very vulnerable. Now we are certain there will be no buyout the shorts should feel much more secure and in control till buyers smell an opportunity. It will happen. When? I don't know obviously but it will happen. The opportunity is just too obvious and getting bigger every time we drop in market cap. The last time I bought was about 2 years ago and I was paying 2-3$ a share. From my perspective now seems to be an amazingly better risk adjusted entry point. JPG Excellent post, that is also why George Rho talked about short term disappointment as he alluded to preferring to see a BO...you can be sure he is not a big fan of the short side and their games. The fact remains give or take some shares that they still have that open position and they never know when that white swan event may take place from left field....what do you think their reaction would be to a sudden announcement regarding an unplanned material event which could effect the course of the companies ownership, just saying you never know, always expect the unexpected. |
|
|
|
Post by babaoriley on Aug 13, 2014 0:18:32 GMT -5
What the company ought to do now is change the name of "Afrezza" to "Exubera" - I'm sure Pfizer would be willing to license the name on the cheap! Perhaps that would make the stock go up, cuz all this other supposedly "good" news doesn't work at all.
|
|
